Derek Lowe reminds us that some of the Big Pharma companies out there have BIG BIG BIG revenue holes to fill between now and 2020. Take a look at both Lilly and AZ's challenges ahead. Though Pfizer ain't far behind itself. Looks like AZ's whether by his choice or the board's go out while the getting's good.
See here for yourself! The graph shows Big Pharma's expected revenues through 2020 on its existing product portfolio. Lilly and AZ? All we can say is "OUCH".
Posted by Bruce Lehr Apr 30th 2012.